JP2025505229A5 - - Google Patents

Info

Publication number
JP2025505229A5
JP2025505229A5 JP2024547302A JP2024547302A JP2025505229A5 JP 2025505229 A5 JP2025505229 A5 JP 2025505229A5 JP 2024547302 A JP2024547302 A JP 2024547302A JP 2024547302 A JP2024547302 A JP 2024547302A JP 2025505229 A5 JP2025505229 A5 JP 2025505229A5
Authority
JP
Japan
Prior art keywords
composition according
pyrrolidine
carbonyl
butyl
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505229A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2023/001712 external-priority patent/WO2023153762A1/ko
Publication of JP2025505229A publication Critical patent/JP2025505229A/ja
Publication of JP2025505229A5 publication Critical patent/JP2025505229A5/ja
Pending legal-status Critical Current

Links

JP2024547302A 2022-02-08 2023-02-07 稀少遺伝性肥満症の予防または治療におけるメラノコルチン-4受容体アゴニストの使用 Pending JP2025505229A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20220016377 2022-02-08
KR10-2022-0016377 2022-02-08
PCT/KR2023/001712 WO2023153762A1 (ko) 2022-02-08 2023-02-07 멜라노코르틴-4 수용체 효능제의 희귀성 유전적 비만질환의 예방 또는 치료에서의 용도

Publications (2)

Publication Number Publication Date
JP2025505229A JP2025505229A (ja) 2025-02-21
JP2025505229A5 true JP2025505229A5 (cg-RX-API-DMAC7.html) 2026-02-17

Family

ID=87564659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547302A Pending JP2025505229A (ja) 2022-02-08 2023-02-07 稀少遺伝性肥満症の予防または治療におけるメラノコルチン-4受容体アゴニストの使用

Country Status (13)

Country Link
US (1) US20250134898A1 (cg-RX-API-DMAC7.html)
EP (1) EP4461297A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025505229A (cg-RX-API-DMAC7.html)
KR (1) KR20230120106A (cg-RX-API-DMAC7.html)
CN (1) CN119300835A (cg-RX-API-DMAC7.html)
AR (1) AR128463A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023218785A1 (cg-RX-API-DMAC7.html)
CA (1) CA3248118A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002389A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024011882A2 (cg-RX-API-DMAC7.html)
MX (1) MX2024009854A (cg-RX-API-DMAC7.html)
TW (1) TWI838114B (cg-RX-API-DMAC7.html)
WO (1) WO2023153762A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3202315A1 (en) * 2020-12-22 2022-06-30 Hee Dong Park Use as selective agonist of malanocortin-4 receptor
KR20250046623A (ko) * 2023-09-27 2025-04-03 주식회사 엘지화학 멜라노코르틴-4 수용체 효능제의 pcsk1 결핍 적응증과 연관된 희귀성 유전적 비만질환의 예방 또는 치료 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI332501B (en) * 2006-07-14 2010-11-01 Lg Life Sciences Ltd Melanocortin receptor agonists
US12516047B2 (en) * 2019-11-07 2026-01-06 Lg Chem, Ltd. Melanocortin-4 receptor agonists
CN116507615A (zh) * 2020-10-29 2023-07-28 株式会社Lg化学 黑皮质素受体激动剂化合物的晶型i及其制备方法
TWI804170B (zh) * 2021-01-21 2023-06-01 南韓商Lg化學股份有限公司 黑皮質素-4受體促效劑的用途
TWI826938B (zh) * 2021-02-26 2023-12-21 南韓商Lg化學股份有限公司 黑皮質素-4受體促效劑
TWI861780B (zh) * 2022-03-28 2024-11-11 南韓商Lg化學股份有限公司 預防或治療肥胖的聯合療法

Similar Documents

Publication Publication Date Title
JP2021063088A5 (cg-RX-API-DMAC7.html)
JP2022096662A5 (cg-RX-API-DMAC7.html)
JP2023512175A5 (cg-RX-API-DMAC7.html)
JP2024516371A5 (cg-RX-API-DMAC7.html)
JP2006182786A5 (cg-RX-API-DMAC7.html)
JP2023166406A5 (cg-RX-API-DMAC7.html)
JPWO2023054292A5 (cg-RX-API-DMAC7.html)
JP2017537158A5 (cg-RX-API-DMAC7.html)
JP2013525318A5 (cg-RX-API-DMAC7.html)
JP2004526788A5 (cg-RX-API-DMAC7.html)
JP2005533860A5 (cg-RX-API-DMAC7.html)
JP2024504252A5 (cg-RX-API-DMAC7.html)
JP2024541569A5 (cg-RX-API-DMAC7.html)
JP2002520316A5 (cg-RX-API-DMAC7.html)
JP2025509088A5 (cg-RX-API-DMAC7.html)
JP2009511450A5 (cg-RX-API-DMAC7.html)
JP2010533131A5 (cg-RX-API-DMAC7.html)
JP2008534453A5 (cg-RX-API-DMAC7.html)
WO2019046287A1 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEPATITIS B
RU2015138443A (ru) Способы лечения ангионевротического отека, опосредованного рецепторами брадикинина в2
JP2022523368A5 (cg-RX-API-DMAC7.html)
JP2025508071A5 (cg-RX-API-DMAC7.html)
JP2024524273A5 (cg-RX-API-DMAC7.html)
JP2025508359A5 (cg-RX-API-DMAC7.html)
JP2005517665A5 (cg-RX-API-DMAC7.html)